4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001437749-17-017234
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Silverman Joshua · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-10-16 | Grant or award : show line 1 in the form Non-Qualified Stock Options (Right to Buy) | +45,000 | 45,000 | D |
Loading xslF345X03/rdgdoc.xml…